Onfi and Reglan drug interactions - from FDA reports

Summary

Drug interactions are reported among people who take Onfi and Reglan together. This study is created by eHealthMe based on reports of 6 people who take Onfi and Reglan from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on clobazam and metoclopramide hydrochloride (the active ingredients of Onfi and Reglan, respectively), and Onfi and Reglan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Onfi?

Onfi has active ingredients of clobazam. It is often used in epilepsy. (latest outcomes from Onfi 4,102 users)

What is Reglan?

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in nausea. (latest outcomes from Reglan 25,338 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 16, 2019

6 people who take Onfi, Reglan are studied.


Number of reports submitted per year:

Onfi and Reglan drug interactions.

Most common drug interactions over time *:

< 1 month:

n/a

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:
  1. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  2. Cardiac disorder
  3. Osteoporosis (bones weak and more likely to break)
  4. Road traffic accident
  5. Skin bacterial infection
  6. Dyspnoea (difficult or laboured respiration)
  7. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  8. Oxygen saturation decreased
  9. Pneumonia
  10. Pyrexia (fever)

Most common drug interactions by gender *:

female:
  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Road traffic accident
  3. Skin bacterial infection
male:
  1. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  2. Cardiac disorder
  3. Dyspnoea (difficult or laboured respiration)
  4. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  5. Oxygen saturation decreased
  6. Pneumonia
  7. Pyrexia (fever)
  8. Rhinovirus infection
  9. Urinary tract infection
  10. Osteoporosis (bones weak and more likely to break)

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:
  1. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  2. Cardiac disorder
  3. Dyspnoea (difficult or laboured respiration)
  4. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  5. Oxygen saturation decreased
  6. Pneumonia
  7. Pyrexia (fever)
  8. Rhinovirus infection
  9. Urinary tract infection
  10. Osteoporosis (bones weak and more likely to break)
20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Onfi and Reglan?


You are not alone:




Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Onfi and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Reglan and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Onfi and Reglan
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Onfi and Reglan (8,190 reports studied)



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!